Results 61 to 70 of about 1,158 (177)
Process For The Preparation of Teduglutide [PDF]
The present invention relates to a process for the preparation of ...
, Srinivasan Thirumalai Rajan; Ghojala Venkat Reddy; Katta Laxmi Reddy; Koduru Venkata Subba Reddy; Ayinavalli Ramesh Babu; MSN Life Sciences Private Limited, Unit-II; Hyderabad, India
core +1 more source
Retrospective chart review of immobilized lipase cartridge use in children with short bowel syndrome
Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 6, Page 1488-1494, June 2026.Abstract This retrospective, single‐center chart review studied the use of an in‐line, immobilized lipase cartridge (ILC) in children with short bowel syndrome (SBS) at Children's Mercy Hospital. For parenteral nutrition (PN)‐dependent patients, the primary endpoint was enteral feeding progression, evaluated by comparing monthly change from baseline in
Elizaveta Khenner +6 more
wiley +1 more source
Teduglutide for the treatment of patients with short bowel syndrome
, 2021 This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the safety and efficacy of teduglutide for the treatment of patients with short bowel syndrome when compared with placebo or no ...
Villarroel del Pino, Luis A +10 more
core +1 more source
Short bowel syndrome and intestinal failure in adults: Anatomy-driven phenotypes, adaptation biology, and contemporary intestinal rehabilitation [PDF]
Halo 194Short bowel syndrome (SBS) is the leading cause of chronic intestinal failure in adults and most commonly follows extensive small-bowel resection. The resulting loss of absorptive surface and regulatory feedback leads to a spectrum of malabsorption ...
Stojanović Bojan +6 more
doaj +1 more source
Clinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.Abstract Intestinal failure‐associated liver disease occurs in 20% to 30% of patients with short bowel syndrome and intestinal failure (SBS‐IF). Apraglutide is a glucagon‐like peptide‐2 (GLP‐2) analog in clinical development for the treatment of patients with SBS‐IF.
Gerard Greig +4 more
wiley +1 more source
Therapeutic Advances in Gastroenterology, 2012 Short bowel syndrome results from surgical resection, congenital defect or disease-associated loss of absorption. Parenteral support (PS) is lifesaving in patients with short bowel syndrome and intestinal failure who are unable to compensate for their ...
Palle Bekker Jeppesen
doaj +1 more source
Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers
Small Methods, Volume 10, Issue 2, 22 January 2026.Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz +5 more
wiley +1 more source
Intestinal FailureMultivisceral transplantation (MVT) is an increasingly utilized option for patients with complex abdominal pathology. However, complications such as graft rejection and post-transplant lymphoproliferative disorder (PTLD) may result in recurrent ...
Royston Antony Fernandes +6 more
doaj +1 more source
Short Bowel Syndrome and Kidney Transplantation: Challenges, Outcomes, and the Use of Teduglutide
Case Reports in Transplantation, 2020 Among patients with short bowel syndrome who commonly have kidney disease, kidney transplantation remains challenging. We describe the clinicopathologic course of a 59-year old man with short bowel syndrome secondary to Crohn’s disease who underwent a ...
Elizabeth Abou Diwan +8 more
doaj +1 more source
Journal of International Medical Research, 2022 Short bowel syndrome (SBS) is a clinical condition characterized by a failure to achieve optimal intestinal adaptation, which is necessary to maintain oral/enteral autonomy.
Changzhen Zhu, Yuanxin Li
doaj +1 more source